Dr Reddys Laboratories Ltd share price
Dr Reddys Laboratories Ltd (DRREDDY) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ which star investors hold it and who is buying it on today's bulk/block deals tape.
Dr. Reddy's Laboratories Limited value chain โ customers, suppliers & competitors
Dr. Reddy's Laboratories is a major Indian pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), generic medicines, and biosimilars globally, sitting between chemical raw material suppliers and global healthcare consumers.
๐ Customers โ who buys from Dr. Reddy's Laboratories Limited
- Global Retail Pharmacies and Distributors โ generic formulations
- Hospitals and Healthcare Institutions โ injectables and biosimilars
โ๏ธ Suppliers โ raw materials & inputs
- Chemical and Solvents Suppliers โ basic petrochemicals and intermediates
- Active Pharmaceutical Ingredient (API) Intermediates โ starting materials
โ๏ธ Competitors โ other sellers
- Sun Pharmaceutical Industries Limited โ Competes globally in generics and specialty drugs; larger in market size
- Cipla Limited โ Competes in respiratory and generic drug segments
- Lupin Limited โ Competes in global generic formulations and APIs
๐ Other suppliers to its customers
- Sun Pharmaceutical Industries Limited โ Alternative supplier of generic drugs to global pharmacies
- Cipla Limited โ Alternative provider of pharmaceutical formulations
๐ค Peers that share its suppliers
- Sun Pharmaceutical Industries Limited โ Also sources chemical intermediates and raw materials globally
- Lupin Limited โ Shares common chemical and raw material supply chains
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.